Pharmacokinetic Pilot Study on Budesonide/Formoterol
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess and compare the Pharmacokinetic (PK) of Budesonide and
Formoterol after administration of 3 different product variants of Budesonide/Formoterol
Easyhalers and Symbicort turbuhaler.
Phase:
N/A
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate